Raymond James & Associates’s Nuveen Tax-Advantaged Total Return Strategy Fund JTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-99,274
| Closed | -$1.1M | – | 4392 |
|
|
2021
Q3 | $1.1M | Buy |
99,274
+1,570
| +2% | +$18K | ﹤0.01% | 2512 |
|
|
2021
Q2 | $1.14M | Buy |
97,704
+10,570
| +12% | +$120K | ﹤0.01% | 2498 |
|
|
2021
Q1 | $936K | Buy |
87,134
+16,250
| +23% | +$164K | ﹤0.01% | 2560 |
|
|
2020
Q4 | $668K | Buy |
70,884
+35,165
| +98% | +$304K | ﹤0.01% | 2609 |
|
|
2020
Q3 | $286K | Sell |
35,719
-2,560
| -7% | -$21.3K | ﹤0.01% | 2985 |
|
|
2020
Q2 | $309K | Buy |
38,279
+82
| +0.2% | +$647 | ﹤0.01% | 2903 |
|
|
2020
Q1 | $269K | Buy |
38,197
+250
| +0.7% | +$2.61K | ﹤0.01% | 2843 |
|
|
2019
Q4 | $458K | Sell |
37,947
-2,963
| -7% | -$34.2K | ﹤0.01% | 2796 |
|
|
2019
Q3 | $461K | Buy |
40,910
+1,021
| +3% | +$11.5K | ﹤0.01% | 2707 |
|
|
2019
Q2 | $456K | Sell |
39,889
-648
| -2% | -$7.56K | ﹤0.01% | 2749 |
|
|
2019
Q1 | $466K | Sell |
40,537
-4,547
| -10% | -$51.6K | ﹤0.01% | 2708 |
|
|
2018
Q4 | $458K | Sell |
45,084
-413
| -0.9% | -$4.82K | ﹤0.01% | 2605 |
|
|
2018
Q3 | $616K | Buy |
45,497
+27
| +0.1% | +$363 | ﹤0.01% | 2568 |
|
|
2018
Q2 | $585K | Buy |
45,470
+4,719
| +12% | +$62.6K | ﹤0.01% | 2571 |
|
|
2018
Q1 | $530K | Buy |
40,751
+764
| +2% | +$10.5K | ﹤0.01% | 2533 |
|
|
2017
Q4 | $558K | Buy |
39,987
+144
| +0.4% | +$1.95K | ﹤0.01% | 2468 |
|
|
2017
Q3 | $547K | Buy |
39,843
+51
| +0.1% | +$670 | ﹤0.01% | 2429 |
|
|
2017
Q2 | $513K | Buy |
39,792
+28,844
| +263% | +$362K | ﹤0.01% | 2400 |
|
|
2017
Q1 | $134K | Hold |
10,948
| – | – | ﹤0.01% | 3028 |
|
|
2016
Q4 | $124K | Buy |
+10,948
| New | +$125K | ﹤0.01% | 2989 |
|
|
2016
Q3 | – | Sell |
-11,430
| Closed | -$129K | – | 3379 |
|
|
2016
Q2 | $129K | Buy |
+11,430
| New | +$129K | ﹤0.01% | 2758 |
|
|
2015
Q2 | – | Sell |
-18,272
| Closed | -$247K | – | 2521 |
|
|
2015
Q1 | $247K | Sell |
18,272
-7,887
| -30% | -$106K | ﹤0.01% | 2273 |
|
|
2014
Q4 | $348K | Sell |
26,159
-50
| -0.2% | -$666 | ﹤0.01% | 2073 |
|
|
2014
Q3 | $363K | Sell |
26,209
-2,518
| -9% | -$36.4K | ﹤0.01% | 1969 |
|
|
2014
Q2 | $431K | Sell |
28,727
-7,328
| -20% | -$104K | ﹤0.01% | 1909 |
|
|
2014
Q1 | $500K | Buy |
36,055
+5,774
| +19% | +$77.9K | ﹤0.01% | 1786 |
|
|
2013
Q4 | $427K | Buy |
30,281
+771
| +3% | +$10.1K | ﹤0.01% | 1734 |
|
|
2013
Q3 | $369K | Buy |
29,510
+6,165
| +26% | +$78.8K | ﹤0.01% | 1709 |
|
|
2013
Q2 | $289K | Buy |
+23,345
| New | +$286K | ﹤0.01% | 1725 |
|
Raymond James & Associates's JTA Position: Q4 2021 in Review
Raymond James & Associates sold out of Nuveen Tax-Advantaged Total Return Strategy Fund (JTA) in Q4 2021, closing a stake of 99,274 shares — an estimated $1.1M sold.
Raymond James & Associates first reported a position in JTA in Q2 2013 and held it in 29 quarters. The position peaked at $1.14M in Q2 2021. 0 funds tracked by Wall St. Rank hold JTA as of Q4 2021.
- Raymond James & Associates reported no remaining Nuveen Tax-Advantaged Total Return Strategy Fund position as of Q4 2021 after selling out during the quarter.
- Raymond James & Associates sold 99,274 Nuveen Tax-Advantaged Total Return Strategy Fund shares in Q4 2021, an estimated $1.1M.
- Raymond James & Associates first reported a position in Nuveen Tax-Advantaged Total Return Strategy Fund in Q2 2013 and held it in 29 quarters.
- Raymond James & Associates's Nuveen Tax-Advantaged Total Return Strategy Fund position peaked at $1.14M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Nuveen Tax-Advantaged Total Return Strategy Fund as of Q4 2021.
Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.